Tellimer

US : argenx SE - ARGX | 1Q Update: Gearing Up for Efgartigimod Approval/Launch; Other Programs Progressing as Planned


Most Viewed See latest
Disclosures

This publication is being distributed by Tellimer solely for information purposes irrespective of a particular user's means, financial situation or investment objectives. The information does not con...

Full Tellimer disclaimers